Skip to main content
Premium Trial:

Request an Annual Quote

Shares in Bruker Slide 6.3 Percent as AXS Shines, Daltonics Disappoints

This article has been updated to include share price and details.

NEW YORK, Nov. 4 (GenomeWeb News) - Shares in Bruker BioSciences were down 6.27 percent at $3.13 in late-afternoon trade--six cents above their 52-week high--despite modest third-quarter revenue.


Bruker also said it will announce further cost-cutting and restructuring measures within the next two months.


In  September, the company laid off around 60 employees worldwide in a move expected to save the company $6 million. Further details of the upcoming restructuring plans were not disclosed.


An increase in sales from its Bruker AXS unit, which makes X-ray systems, helped the company report $66.6 million in total receipts in the third quarter up from $63.1 million during the same period last year.


Sales in the Bruker's AXS unit increased to $32.3 million from $26.8 million, while revenues from Bruker Daltonics, which makes mass spectrometry systems, declined to $34.2 million from $36.3 million.


Frank Laukien, Bruker's CEO, said in a statement yesterday that some new products had only recently started to be shipped, and that some revenue could not be booked yet because customers were not ready to have their systems installed.


R&D costs for the quarter increased to $11.3 million from $9.6 million during the same period last year.


Net loss in the quarter fell to $2.7 million, or $.03 per share, from $14.7 million, or $.17 per share, year over year. This net loss included a $1.6 million write-off of remaining investments in two proteomics companies. Bruker did not disclose the identities of the two firms.


As of Sept. 30, Bruker had $76.6 million in cash and short-term investments.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.